Clinical Trial to Evaluate the Efficacy of Bifidobacterium BB-12® in the Treatment of Infantile Colic

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 11, 2016

Primary Completion Date

November 6, 2017

Study Completion Date

November 6, 2017

Conditions

Infantile ColicColic, Infantile

Interventions

DIETARY_SUPPLEMENT

Bifidobacterium, BB-12® (Bifidolactis Infant)

DIETARY_SUPPLEMENT

Bifidolactis Infant Placebo

Trial Locations (1)

"Dipartimento di Scienze Mediche Traslazionali - Sezione Pediatria - Università degli Studi di napoli Federico II", Napoli

All Listed Sponsors

lead

SOFAR S.p.A.

INDUSTRY

NCT03434249 - Clinical Trial to Evaluate the Efficacy of Bifidobacterium BB-12® in the Treatment of Infantile Colic | Biotech Hunter | Biotech Hunter